![]() |
|
|
Vol. 287, Issue 2, 766-772, November 1998
Division of Neurology and the Brain and Behavior Program, Interaction of
-aminobutyric acid (GABA), pentobarbital and two
neuroactive steroids on t-butylbicyclophosphorothionate
([35S]TBPS) binding to GABAA receptors in
thalamus was studied during absence seizures. In control brain
sections, the steroids alphaxalone and tetrahydrodeoxycorticosterone
(at low 0.1-1 µM concentrations) increased [35S]TBPS
binding in thalamic relay nuclei. Both GABA and pentobarbital dose-dependently decreased [35S]TBPS binding in these
nuclei. A significant decrease in the ability of steroids to increase
[35S]TBPS binding in thalamic relay nuclei was observed
during absence seizures induced by
-hydroxybutyric acid (GHB). This
loss of steroid effect on binding was 1) selective to steroids only as GABA and pentobarbital modulation of [35S]TBPS binding in
these nuclei did not change significantly and 2) not causally related
to the generation of GHB-induced absence seizures as it was not
observed at the onset of GHB-seizures but developed 30 min after the
seizure-onset. We tested whether absence seizures were critical for the
development of this loss of steroid effect on [35S]TBPS
binding in thalamic relay nuclei. The ability of the steroids to
increase [35S]TBPS binding in relay nuclei was preserved
when GHB-seizures were blocked. When the duration of GHB-seizures was
prolonged, the loss of steroid effect on [35S]TBPS
binding in thalamus persisted throughout the seizure-duration. These
findings suggest that absence seizures cause a rapid loss of steroid
effect on [35S]TBPS binding to GABAA
receptors in thalamic relay nuclei.
0022-3565/98/2872-0766$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
P. K. Banerjee, R. W. Olsen, and O. C. Snead III Zinc Inhibition of gamma -Aminobutyric AcidA Receptor Function Is Decreased in the Cerebral Cortex during Pilocarpine-Induced Status Epilepticus J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 361 - 366. [Abstract] [Full Text] |
||||